Literature DB >> 27184878

Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Adverse cognitive and behavioural effects of antiepileptic drugs in children.

Albert Aldenkamp1, Frank Besag2, Giuseppe Gobbi3, Rochelle Caplan4, David W Dunn5, Matti Sillanpää6.   

Abstract

The literature was evaluated for cognitive and more general behavioural effects. We distinguished the older antiepileptic drugs (AEDs), from the newer and newest AEDs. The striking finding was the lack of information on children. From the available evidence it would appear that there may be negative cognitive effects with phenobarbital, phenytoin, topiramate and zonisamide, and adverse behavioural effects with phenobarbital, valproate, gabapentin, topiramate, levetiracetam and zonisamide. There is inconclusive data on ethosuximide, clobazam, vigabatrin, felbamate, pregabalin, stiripentol, rufinamide, lacosamide and retigabine. The following drugs appear to be neutral with regard to cognitive effects: valproate, carbamazepine, gabapentin and oxcarbazepine. Carbamazepine appears to be neutral with regard to behavioural effects. Positive cognitive effects have been reported with lamotrigine and levetiracetam. Positive behavioural effects have been reported with lamotrigine. Recommendations are provided.

Entities:  

Keywords:  antiepileptic drug; attention; cognition; memory

Year:  2016        PMID: 27184878     DOI: 10.1684/epd.2016.0817

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  14 in total

1.  Utility of oxcarbazepine in the treatment of childhood and adolescent psychiatric symptoms.

Authors:  Kyle Morrow; Keith A Young; Shawn Spencer; Edgar Samuel Medina; Michaela A Marziale; Alejandro Sanchez; James A Bourgeois
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-06

2.  Behavior Problems in Childhood Absence Epilepsy: A Chicken or Egg Problem.

Authors:  Jay Salpekar
Journal:  Epilepsy Curr       Date:  2018 Mar-Apr       Impact factor: 7.500

Review 3.  The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity.

Authors:  Alberto Verrotti; Romina Moavero; Gianvito Panzarino; Claudia Di Paolantonio; Renata Rizzo; Paolo Curatolo
Journal:  Clin Drug Investig       Date:  2018-01       Impact factor: 2.859

Review 4.  Language Dysfunction in Pediatric Epilepsy.

Authors:  Fiona M Baumer; Aaron L Cardon; Brenda E Porter
Journal:  J Pediatr       Date:  2017-12-11       Impact factor: 4.406

5.  Guided self-help interventions for mental health disorders in children with neurological conditions: study protocol for a pilot randomised controlled trial.

Authors:  Sophie Bennett; Isobel Heyman; Anna Coughtrey; Jess Simmonds; Sophia Varadkar; Terence Stephenson; Margaret DeJong; Roz Shafran
Journal:  Trials       Date:  2016-11-04       Impact factor: 2.279

Review 6.  Epilepsy in patients with autism: links, risks and treatment challenges.

Authors:  Frank Mc Besag
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-18       Impact factor: 2.570

7.  Playing soft, with tough players: Controlling adverse drug effects while tuning antiepileptic drugs, epilepsy & the person.

Authors:  Dejan Stevanovic
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

Review 8.  Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review.

Authors:  Lu Lu; Weixi Xiong; Yingying Zhang; Yingfeng Xiao; Dong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

9.  Commentary: Acute Tension-Type Headaches Are Associated with Impaired Cognitive Function and More Negative Mood.

Authors:  Marcelo M Valença
Journal:  Front Neurol       Date:  2016-06-30       Impact factor: 4.003

10.  Anti-Epileptic Drug Toxicity in Children.

Authors:  Imti Choonara
Journal:  Children (Basel)       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.